Screening Drug-Induced Arrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays
Author(s) -
Enrique G. Navarrete,
Ping Liang,
Feng Lan,
Verónica Sánchez-Freire,
Chelsey S. Simmons,
Tingyu Gong,
Arun Sharma,
Paul W. Burridge,
Bhagat Patlolla,
Andrew S. Lee,
Haodi Wu,
Ramin E. Beygui,
Sean M. Wu,
Robert C. Robbins,
Donald M. Bers,
Joseph C. Wu
Publication year - 2013
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.112.000570
Subject(s) - induced pluripotent stem cell , quinidine , medicine , herg , afterdepolarization , multielectrode array , pharmacology , embryoid body , sotalol , cardiotoxicity , drug , embryonic stem cell , electrophysiology , potassium channel , microelectrode , repolarization , atrial fibrillation , toxicity , biology , chemistry , biochemistry , electrode , gene
Drug-induced arrhythmia is one of the most common causes of drug development failure and withdrawal from market. This study tested whether human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) combined with a low-impedance microelectrode array (MEA) system could improve on industry-standard preclinical cardiotoxicity screening methods, identify the effects of well-characterized drugs, and elucidate underlying risk factors for drug-induced arrhythmia. hiPSC-CMs may be advantageous over immortalized cell lines because they possess similar functional characteristics as primary human cardiomyocytes and can be generated in unlimited quantities.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom